Pulse Check: The Cardiovascular Conversations | Ep. 2 | Coronary Imaging Innovation and the Path to Targeted Therapies

In episode two, the conversation turns to clinical development and the power of imaging biomarkers. Dr. Cheerag Shirodaria (Fortrea) and Chris Farina (Abcentra) delve into how innovations in technology and imaging, such as coronary CT angiography (CCTA) and the Fat Attenuation Index (FAI) are transforming risk stratification—reclassifying patients and identifying inflammation even in those with “normal” arteries. The episode also highlights the challenges of trial design in novel populations and the critical role of sponsor-CRO-vendor collaborations, including Fortrea’s CRO support. For pharma teams focused on precision medicine and inflammation-targeted therapies, this episode offers valuable insights into the future of cardiovascular care.